Stephan Bernhardt
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
-
- Epigenetics and DNA Methylation 4
- Gene expression and cancer classification 4
- Advanced Biosensing Techniques and Applications 4
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Trond Buanes (4 shared papers)Mona Møller (2 shared papers)Jon Amund Eriksen (3 shared papers)Dagmar S. Trachsel (1 shared paper)Gustav Gaudernack (3 shared papers)Ulrike Korf (8 shared papers)Stefan Wiemann (8 shared papers)Tim Beißbarth (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Scientific Reports (2 papers)Future Oncology (2 papers)British Journal of Cancer (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Stephan Bernhardt
21 papers receiving 488 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 120
- Oncology 208
- Immunology 157
- Biotechnology 53
- Molecular Biology 277
Countries citing papers authored by Stephan Bernhardt
This map shows the geographic impact of Stephan Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Bernhardt more than expected).
Fields of papers citing papers by Stephan Bernhardt
This network shows the impact of papers produced by Stephan Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Bernhardt. The network helps show where Stephan Bernhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephan Bernhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 238 | |
| 2 | 2017 | 80 | |
| 3 | 2014 | 32 | |
| 4 | 2018 | 25 | |
| 5 | 2020 | 21 | |
| 6 | 2016 | 15 | |
| 7 | 2014 | 13 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 11 | |
| 10 | 2015 | 11 | |
| 11 | 2019 | 7 | |
| 12 | 2005 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2011 | 5 | |
| 16 | 2022 | 3 | |
| 17 | 2014 | 3 | |
| 18 | 2007 | 3 | |
| 19 | 2008 | 2 | |
| 20 | 2020 | 1 |
About Stephan Bernhardt
Stephan Bernhardt is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 498 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Renal cell carcinoma treatment (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Immunotherapy and Immune Responses (4 papers), Gene expression and cancer classification (4 papers), Advanced Biosensing Techniques and Applications (4 papers), Economic and Financial Impacts of Cancer (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Cancer Research (120 citations), Oncology (208 citations), Immunology (157 citations), Biotechnology (53 citations) and Molecular Biology (277 citations). Stephan Bernhardt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Trond Buanes, Mona Møller, Jon Amund Eriksen, Dagmar S. Trachsel, Gustav Gaudernack, Ulrike Korf, Stefan Wiemann, Tim Beißbarth, Astrid Wachter and Martina Vetter. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports, Future Oncology, British Journal of Cancer and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.